Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
2023 · Journal of Experimental & Clinical Cancer Research · 25 citations
https://doi.org/10.1186/s13046-023-02750-w
T
Tarang Gaur
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
50
Citations
3
h-index
2
i10-index
Tarang Gaur is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Cancer-related Molecular Pathways & Cancer therapeutics and mechanisms. The author has an h-index of 3, co-authored 12 publications.
Papers by this author
worksBIRC5 upregulation enhances DNMT3A-mutant T-ALL cell survival and pathogenesis
2024 · Blood Neoplasia · 1 citations
https://doi.org/10.1016/j.bneo.2024.100040
Additional file 1 of Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.23803051
Additional file 2 of Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.23803054
Additional file 3 of Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.23803057
A Covalent CDK7 Inhibitor Overcomes Venetoclax Resistance and Induces Apoptosis via C-Myc/p53 Axis in Acute Myeloid Leukemia
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)00508-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat